References
- Blanchard K, Clark S, Winikoff B, Gaines G, Kabani G, Shannon C. Misoprostol for women's health: a review. Obstet Gynecol 2002; 99: 316–32
- Ekerhovd E, Radulovic N, Norström A. Gemeprost versus misoprostol for cervical priming before first-trimester abortion: a randomized controlled trial. Obstet Gynecol 2003; 101: 722–5
- Singh K, Fong YF, Prasad RNV, Dong F. Vaginal misoprostol for pre-induction cervical priming: is there an optimal evacuation time interval?. Br J Obstet Gynaecol 1997; 106: 266–9
- Thomson AJ, Lunan CB, Cameron AD, Cameron IT, Greer IA, Norman JE. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br J Obstet Gynecol 1997; 104: 1054–7
- Thomson AJ, Lunan CB, Ledingham M, Howat RC, Cameron IT, Greer IA, et al. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy. Lancet 1998; 352: 1093–6
- Facchinetti F, Piccinini F, Volpe A. Chemical ripening of the cervix with intracervical application of sodium nitroprusside: a randomised controlled trial. Hum Reprod 2000; 15: 2224–7
- CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191–4
- Fisher J, Anthony GS, McManus TJ, Coutts JR, Calder AA. Use of a force measuring instrument during cervical dilatation. J Med Eng Technol 1981; 5: 194–5
- Henshaw RC, Templeton AA. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486). Br J Obstet Gynaecol 1991; 98: 1025–30
- Fong YF, Singh K, Prasad RNV. A comparative study using two dose regimens (200 µg or 400 µg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae. Br J Obstet Gynaecol 1998; 105: 413–7
- Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol 1990; 76: 129–35
- World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems. WHO, Geneva 2003
- Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. Evidence-based Clinical Guideline Number 7. RCOG Press, London 2004
- Singh K, Fong YF, Prasad RNV, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol 1998; 5: 795–8
- Li CFI, Chan CWC, Ho PC. A comparison of isosorbide mononitrate and misoprostol cervical ripening before suction evacuation. Obstet Gynecol 2003; 102: 583–8
- Abshagen U. Pharmacokinetics of isosorbide mononitrate. Am J Cardiol 1992; 70: 61G–66G
- Bates CD, Nicoll AE, Mullen AB, Mackenzie F, Thomson AJ, Norman JE. Serum profile of isosorbide mononitrate after vaginal administration in the third trimester. BJOG 2003; 110: 64–7